Gaiberg, Germany

Martin Zeier

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Tolerogenixx Gmbh, Universitat Heidelberg. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Zeier. Retrieved from https://idiyas.com/inventor/martin-zeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Zeier: Innovator in Immunosuppression Therapy

Introduction

Martin Zeier is a notable inventor based in Gaiberg, Germany. He has made significant contributions to the field of immunosuppression, particularly in transplantation medicine. His innovative approach focuses on utilizing specific immunosuppressive therapies to improve patient outcomes.

Latest Patents

Martin Zeier holds a patent for his invention titled "MIC therapy for specific immunosuppression in transplantation." This patent involves pharmaceutical compositions that utilize isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs). The invention aims to prevent and/or treat organ or cell graft rejection in human graft recipients, showcasing a promising advancement in transplantation therapies. He has 1 patent to his name.

Career Highlights

Throughout his career, Martin Zeier has worked with reputable organizations, including Tolerogenixx GmbH and Universität Heidelberg. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in immunology and transplantation.

Collaborations

Some of his notable coworkers include Christian Morath and Anita Schmitt. Their collaborative efforts have furthered the development of innovative therapies in the realm of immunosuppression.

Conclusion

Martin Zeier's contributions to the field of immunosuppression therapy highlight his dedication to improving patient care in transplantation. His innovative patent and collaborations with esteemed colleagues underscore his impact on medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…